Denver, Colorado-based DaVita Inc. (DVA) provides dialysis services to patients with chronic kidney failure in the United States. The company has a market cap of $11.3 billion and operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. DVA is expected to release its Q3 2026 earnings on Thursday, October 29, 2026, after the market closes.
Ahead of the event, analysts expect the company’s EPS to be $3.78 on a diluted basis, up 50.6% from $2.51 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in three of its last four quarters, while missing on one occasion.